Outgoing GSK boss Dame Emma Walmsley has said the US is the best place to invest, in the latest blow to Britain’s pharmaceutical sector, after a raft of drugs firms have scrapped or paused plans to invest in the UK.

Dame Emma, who is leaving in January after leading GSK as chief executive for the past eight years, told the BBC she would not “shy away” from the firm’s plans to invest in the US, which she said was “still the leading market in the world in terms of the launches of new drugs and vaccines”.

Alongside China, it is the “best market in the world to do business development”, she added.

GSK announced in September it would invest 30 billion dollars (£21.9 billion) in the US over the next five years, which came amid pressure from US President Donald Trump as he stepped up his trade

See Full Page